SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is trending amidst heightened competitive concerns following Amazon Pharmacy's direct offering of Novo Nordisk's GLP-1 weight loss pill, which many in the community view as a significant headwind. While a vocal bearish contingent cites overvaluation and predicts further downside, a segment of investors sees current price levels as a strong buying opportunity, banking on the company's diversified telehealth platform and international expansion. The market is actively debating HIMS's growth trajectory and valuation as it navigates this evolving competitive landscape.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is seeing a surge in attention following positive FDA feedback, which significantly de-risks its lead asset sonelokimab by clarifying a direct regulatory pathway without additional trials. This catalyst, combined with notable insider buying and multiple analyst upgrades, is driving strong community sentiment and fueling speculation for an imminent buyout or substantial re-rating in the competitive immunology market.

NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. Its products include Avenova, NeutroPhase and DERMAdoctor. The company was founded on January 19, 2000 and is headquartered in Emeryville, CA.

Novabay Pharmaceuticals Inc

Novabay Pharmaceuticals (NBY) is experiencing extreme volatility and massive gains, largely fueled by a significant special cash dividend and discussions around a potential pivot to blockchain-based assets. The community is intensely focused on short squeeze potential and the dividend's impact, though many debate the company's underlying fundamentals against the backdrop of its dramatic price movements.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is trending with investors expressing a mix of frustration over recent stock performance and renewed optimism for Briumvi's competitive standing. The community is actively discussing a competitor's recent regulatory setback, which highlights Briumvi's favorable profile, while anticipating potential strategic updates from the upcoming J.P. Morgan Healthcare Conference.

United States Commodity Funds LLC - United States Oil Fund

United States Oil Fund

The United States Oil Fund is trending as escalating U.S. actions in Venezuela, including military operations and blockades, create market uncertainty. Investors are sharply divided: some anticipate a significant oil price surge due to supply disruptions, while others predict eventual price stabilization or declines if new Venezuelan supply comes online and global oversupply persists. The financial community is closely watching the geopolitical implications of this evolving situation.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

ProShares Ultra Bloomberg Natural Gas (BOIL) is trending as unseasonably warm weather continues to dampen heating demand, driving natural gas prices to multi-week lows. This sharp decline has fueled widespread frustration and significant losses among long holders, who are fiercely debating whether a bottom is in or if an anticipated "polar vortex" can ignite a major rebound against the ETF's inherent decay.

Rich Sparkle Holdings Ltd. engages in the provision of financial printing and corporate services. The firm offers typesetting, proofreading, translation, design, and printing of listing documents, financial reports, fund documents, circulars, and announcements. It also delivers advisory services, such as conducting internal control assessment and environmental, social and governance performance evaluation, and other services including provision of co-working space. The company was founded in 2016 and is headquartered in Hong Kong.

Rich Sparkle Holdings Ltd.

Rich Sparkle Holdings Limited

Rich Sparkle Holdings Limited is experiencing intense trading activity following news of a significant private placement and an acquisition, coinciding with the expiration of its IPO lock-up period. This low-float international stock is generating widespread community discussion, with many anticipating a substantial short squeeze and comparing its trajectory to other highly volatile market movers. However, considerable caution is also being voiced, highlighting the speculative nature and potential for rapid price movements.

Stafi is the first DeFi protocol unlocking liquidity of staked assets. Users can stake PoS tokens through Stafi and receive rTokens in return, which are available for trading while still earning staking rewards. FIS is the native token on Stafi Chain. FIS is required to provide security to the network by staking, pay for transaction fees on the Stafi chain, mint &amp; redeem rTokens.

StaFi

StaFi (FIS) is currently trending with significant community discussion around its recently announced token burn proposal, aiming for deflationary tokenomics, and a new roadmap. Despite a recent delisting, strong bullish sentiment persists due to its perceived low market cap and continued presence on major exchanges, with many anticipating substantial upside as a liquid staking protocol.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo Inc. is currently trending due to a significant agreement with Meta Platforms to develop a nuclear energy campus in Ohio, aimed at powering future AI data centers. This deal, alongside anticipated DOE support for fuel and recent discussions on nuclear energy, has fueled intense bullish sentiment regarding the future of small modular reactors for AI infrastructure, despite some community concerns over current revenue and regulatory timelines.

SSgA Active Trust - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

The Energy Select Sector SPDR Fund (XLE) is a major talking point as geopolitical shifts in Venezuela, including reports of US influence over its oil sector, ignite discussions about potential supply changes. This development is fueling community debate, with many anticipating a significant energy sector breakout and capital rotation, while others remain cautious about long-term infrastructure challenges and potential oversupply impacts on oil prices.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ansys, Inc. Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights - ANSS

Ansys, Inc. Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights - ANSS Ansys, Inc. Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your...

ANSS Investors Have Opportunity to Join Ansys, Inc. Fraud Investigation with the Schall Law Firm

ANSS Investors Have Opportunity to Join Ansys, Inc. Fraud Investigation with the Schall Law Firm ANSS Investors Have Opportunity to Join Ansys, Inc. Fraud Investigation with the Schall Law Firm PR...

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Ansys, Inc. (Ansys or the Company) (NASDAQ: ANSS) for...

The Trade Desk Stock Climbs Higher on S&P 500 Debut as ANSYS Drops Out

TTD jumps 6.6% as it joins the S&P 500. The company expects CTV growth, Kokai demand and global ad trends to fuel momentum.

Ansys Acquisition by Synopsys Clears Regulatory Hurdles Worldwide

ANSS moves closer to merging with Synopsys as final global approvals secure $35B deal set to close July 17.

Ansys (ANSS) Moves 3.0% Higher: Will This Strength Last?

Ansys (ANSS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

China's antitrust authority has greenlit Synopsys Inc.(SNPS)'s $35 billion acquisition of engineering software firm Ansys Inc. (ANSS), clearing the final international hurdle for the deal between two key players in&nbsp;the electronic design automation (EDA)&nbsp;industry.According to a Reuters&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/world/china/china-grants-conditional-approval-synopsys-acquire-ansys-2025-07-14/">report</a>, the conditional approval from the State Administration for Market Regulation (SAMR) came just days ahead of the deal’s July 15 closure deadline.&nbsp;Following the news,&nbsp;<a href="https://stocktwits.com/symbol/SNPS">Synopsys stock</a> traded 3.3% higher in Monday’s premarket session.While regulatory bodies in other key global markets had already approved the transaction, doubts lingered over whether Chinese authorities would delay the deal due to ongoing political and trade friction.&nbsp;Investor anxiety grew after the United States imposed limits on the export of specific semiconductor design technologies to China, prompting speculation that Beijing might respond with its countermeasures.Synopsys had&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/synopsys-restarts-partial-services-in-china-amid-us-export-curbs/chlXDS8Rb6s">suspended</a> its services in China in June after U.S. export controls compelled the company to stop sales and support operations. It also&nbsp;paused its financial forecasts for both the third quarter and the fiscal year 2025.&nbsp;The approval arrives just weeks after President Donald Trump’s administration lifted restrictions on exports of critical semiconductor design tools to China.The ban, introduced in May, had impacted not only Chinese customers but also employees of foreign firms operating within China. Its lifting paved the way for the long-pending deal to resume progress, stated a&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.scmp.com/tech/big-tech/article/3318140/tech-war-china-approves-synopsys-acquisition-ansys-after-us-lifts-eda-ban?module=perpetual_scroll_0&amp;pgtype=article">report</a> from SCMP.&nbsp;China's approval was granted under a set of obligations. The merged company is expected to provide Chinese customers with continued, unbiased access to electronic design automation tools.&nbsp;Additionally, the firms must honor all existing agreements, renew interoperability partnerships upon request, and preserve their current contractual commitments in the Chinese market.The deal is expected to bolster Synopsys’ position against rival Cadence, broadening its product suite and deepening its foothold in the EDA sector.&nbsp;On Stocktwits, retail sentiment toward Synopsys shifted to ‘neutral’ from ‘bearish’&nbsp; territory the previous day amid ‘low’ message volume levels.<figure class="image"><img style="aspect-ratio:807/104;" src="https://news.stocktwits-cdn.com/Screenshot_2025_07_14_at_7_27_58_AM_png_9595235e95.webp" alt="SNPS’s Sentiment Meter and Message Volume as of 07:30 a.m. ET on July 14, 2025 | Source: Stocktwits" width="807" height="104"><figcaption>SNPS’s Sentiment Meter and Message Volume as of 07:30 a.m. ET on July 14, 2025 | Source: Stocktwits</figcaption></figure>Synopsys stock has gained over 15% year-to-date and has lost over 9% in the last 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/alphabet-reportedly-strikes-2.4-b-licensing-deal-with-with-windsurf/ch8BFF2R5Vb">Alphabet Reportedly Strikes $2.4B Licensing Deal With Windsurf, Snags Founders And AI Researchers After OpenAI's Failed Bid</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a Synopsys logo is seen displayed on a smartphone with the flag of China in the background. 

Synopsys-Ansys’ $35B Deal Reportedly Gets China’s Conditional Approval Days Before Closure Deadline

China’s approval removes the final global barrier for the deal, with conditions ensuring continued design tool access for Chinese customers and partners.

Equity

China approves Synopsys’ $35 bln Ansys acquisition

Investing.com-- China’s market regulator has provided conditional approval to Synopsys (NASDAQ:SNPS) for its $35 billion acquisition of Ansys (NASDAQ:ANSS), clearing a key regulatory hurdle for the U.S. chip-design software giant

ANSS Simulation Solutions Used by Wingcopter to Boost  Drone Designs

ANSS, Turbotech Team Up to Fuel a Hydrogen-Powered Future in Aviation

ANSYS, Inc. engages in the development and marketing of engineering simulation software and services. The firm's solutions include automotive, aerospace and defense, construction, energy, materials and chemical processing, autonomous engineering, and electrification. The company was founded by John A. Swanson in 1970 and is headquartered in Canonsburg, PA.

Ansys Inc. - Registered Shares

Yes — Rates Move Meaningfully Lower

Short-Term Dip, No Lasting Impact

No — Mostly Political Noise

Other – Comment Below

President Trump says he’s directing $200 billion into mortgage bond purchases to bring down rates and improve housing affordability. With questions around execution, authority, and real market impact, do you think this move will actually lower mortgage rates in 2026?

Will Trump’s Mortgage Bond Plan Actually Lower Rates in 2026?

ANSS
Ansys Inc. - Registered Shares

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ANSS News

ANSSAnsys Inc. - Registered Shares